Executive Summary: Middle East and Africa Coronary Stents Market

Market Scope: Comprehensive Middle East and Africa coronary stents market analysis covering stent types, modes of delivery, materials, end-user settings, and country-level regional frameworks.
Market Valuation: Valued at USD 0.79 billion (2025), estimated at USD 0.86 billion (2026), and projected to reach USD 1.77 billion by 2034, registering a CAGR of 9.44% (2026–2034).
Primary Growth Drivers: High prevalence of cardiovascular diseases, sharp increase in aging populations, rising obesity rates, and the unique advantages of bioabsorbable stents (such as avoiding surgical resection in pediatric surgery and reducing late-stent thrombosis). Key demand is further fueled by sedentary lifestyles, unhealthy dietary habits, and increasing adoption of minimally invasive (MI) surgeries and percutaneous coronary interventions.

Key Market Segment Metrics (2026–2034)

Category	Leading Segment (2025 Position)	Fastest-Growing Segment
By Type	Drug-Eluting Stents & Bare Metal Stents (established standard offerings across conventional regional treatments)	Bioabsorbable Stents (driven by technical advancements and clinical benefits in pediatric and complex surgeries)
By Mode of Delivery	Balloon-Expandable Stents (widely utilized for precise placement in coronary interventions)	Self-Expanding Stents (growing due to increased adoption in complex vascular and peripheral procedures)
By Material	Metallic Stents (including Cobalt-chromium, Platinum-chromium, and Stainless steel variants)	Bioabsorbable and Polymeric Scaffold Materials (advancing through next-gen R&D innovations)
By End User	Hospitals (maintaining the largest share of coronary stent procedures and emergency cardiac care)	Cardiac Centers and Ambulatory Surgical Centers (expanding due to specialized cardiovascular care)
By Country	KSA, UAE, and Israel (holding major regional shares supported by advanced healthcare infrastructure)	South Africa (identified as the fastest-growing region in the MEA bioabsorbable and coronary stent market)

Major Market Players & Market Structure

Market Structure: Competitive medical device landscape shaped by large multinational companies and innovative smaller players launching affordable product variants. Market dynamics are heavily influenced by technological progress, product safety profiles, pricing strategies, and regional cardiovascular disease burdens.

Key Companies: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Stentys SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts, and Translumina GmbH.

Middle East and Africa Coronary Stents Market Size

The Middle East and Africa coronary stent market size was valued at USD 0.79 billion in 2025 and is anticipated to reach USD 0.86 billion in 2026 from USD 1.77 billion by 2034, growing at a CAGR of 9.44% during the forecast period from 2026 to 2034.

Factors that are primarily accelerating the MEA coronary stent market are the high prevalence of cardiovascular disease, a sharp increase in the aging of the population, and the expansion of obese people.

Especially in pediatric surgery, the bioabsorbable stent does not require surgical resection or vascular growth, further promoting the market growth. According to the WHO report, it can be seen that the world's number one cause of death is cardiovascular disease. Also, the World Health Organization estimates that approximately 17.9 million people died of cardiovascular disease (CVD) in 2016, accounting for 31% of the global deaths, 85% of which resulted from heart disease and stroke. According to the Australian Heart Foundation, cardiovascular disease (CVD) is the leading cause of death in Australia. In 2017, 43,477 people died of cardiovascular disease in Australia. Cardiovascular disease kills an Australian every 12 minutes. Therefore, this rise in global CVD prevalence is supposed to drive bioabsorbable market growth in MEA.

The high costs associated with implantation procedures and strict government stent approval regulations hinder the Middle East and Africa bioabsorbable stents market growth. In addition, on September 14, 2017, due to poor sales and safety issues, Abbott announced the termination of the sale of Absorb bioabsorbable vascular stents, which had a substantial negative impact on the market.

Increasing stroke-prone elderly populations require stent implants for treatment. The increasing adoption of these devices, technological advancements, and the risk of restenosis in patients undergoing angioplasty are factors driving the growth of the MEA bioabsorbable stent market. Also, the lack of necessary physical exercise and unhealthy eating habits leads to the development of cardiovascular disease and requires percutaneous coronary intervention. Also, the disappearance of these stents from the treatment site adds advantages, such as reduced late-stent thrombosis and ease of repeat treatment.

With technological progress and product innovation, small and medium-sized companies expand their market share by launching new products at affordable prices. As a result, companies such as Boston Scientific and Arterius Limited are ruling the market and occupying a significant share.

REGIONAL ANALYSIS

The Middle East and Africa bioabsorbable stents market is assumed to occupy a steady share as the adoption of technologically advanced products increases by 2025. In addition, the rise of coronary and peripheral surgeries in the area is increasing the demand for bioabsorbable stents. Furthermore, with the increasing adoption of MI surgery, markets in the Middle East and African countries are growing and can recover faster. As a result, the South Africa market is the fastest-growing region of the bioabsorbable stent market in the MEA.

It is estimated that the elderly population in the Middle East and African countries will increase at a tremendous rate in the coming years, which will promote the development of the bioabsorbable stents market in this vicinity. In addition, other nations like the UAE, Saudi Arabia, Qatar, Kuwait, Egypt, and so on are also contributing to this business growth in the MEA.

KEY MARKET PLAYERS

Some of the major companies operating in the Middle East & Africa Coronary Stent Market include

Medtronic plc (Ireland)
Abbott Laboratories (U.S.)
Boston Scientific Corporation (U.S.)
Biosensors International Group, Ltd. (Singapore)
BIOTRONIK SE & Co. KG (Germany)
B. Braun Melsungen AG (Germany)
TERUMO CORPORATION (Japan)
STENTYS SA (France)
MicroPort Scientific Corporation (China)
Meril Life Sciences Pvt. Ltd. (India)
Vascular Concepts (India)
Translumina GmbH (Germany)

MARKET SEGMENTATION

This research report on the MEA Coronary Stent Market has been segmented and sub-segmented into the following categories.

By Type:

Bare Metal Stents
Drug-Eluting Stents
Bioabsorbable Stents

By Mode of Delivery

Balloon Expandable Stents
Self-Expanding Stents

By Material

Metallic stents
- Cobalt chromium
- Platinum chromium
- Nickel-titanium
- Stainless steel
Other Stents

By End-User

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

By Country

KSA
UAE
Israel
rest of GCC countries
South Africa
Ethiopia
Kenya
Egypt
Sudan
rest of MEA

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Middle East & Africa Coronary Stents Market Report